Cervical Screening in under 25s -the Jade Goody Effect

 22nd Apr 2009

A number of GPs have been approached by women under the screening age of 25years following the tragic death of Jade Goody.

This is advice from Mr John Bevan (Portsmouth Hospitals Trust - Consultant Gynaecologist and lead on Cervical Cytology Screening)

My understanding and opinion is that the current advice remains and is that screening cytology is from age 25 and Jane Goody's cervical cancer should not alter that advice. 'One case makes bad law' The risks of anyone under the age of 25 having cancer is extremely low and there is little evidence that screening prevents that risk. Screening of young women usually fails to prevent the small number of women who would develop cancer under 25 from doing so and leads to unnecessary investigation and treatment.
 
If there are any changes to this advice then we will circulate. However advice on screening clearly should be coming from Public Health Specialists at the PCT.
Clearly screening is a different issue from women with symptoms. If a woman under the age of 25 has symptoms i.e persistent pcb then she should be investigated for infective causes i.e. Chlamydia in the first instance and if concerns are raised about the appearance of the cervix then referral to general gynaecology rather than colposcopy as colposcopy is currently overwhelmed by approx double number of referrals. This is because women who have never been screened  or have dna'd are coming forward to have cytology and clearly this is a group at risk. I would point out that very very rarely do patients referred with abnormal cervices have anything abnormal! Only invasive cancers will be detectable to the naked eye. These would amount to no more than about 20/yr for the whole of our population of 500,000.

Speaking to the laboratories they do not refuse slides from women outside the programme. So our advice is to do what you believe is best for your patient. If she has symptoms she needs a thorough gynae or GU assessment. If she is asymptomatic you may go ahead if you wish but you will need to explain the risks of false positives and negatives in this age group.

FS April 09

 
Home
About us
LMC Communications
Guidance
Certificates and Reports
Complaints
Contractual Issues
Data Protection & Confidentiality
Decontamination
Education,Training, CPD -including revalidation
Electronic Records and IT
Employment issues
Enhanced Services
Financial
Medico-legal
Partnership Issues
PBC
Practice Matters
Advance decisions-advance directive and advance care plans
Asbestos surveys
Bus pass signatures
Business Continuity Plans
Caldicott Guardian
Chaperones
Cervical Smear Tests and Cervical Cytology
Charging Patients
Complaints - ICAS
Complementary Therapy
CQC- Care Quality Commission
Dental Problems
Dental Prophylaxis
Disposal of Sharps and Other Clinical Waste
Falls Protocol for RH and NHs
Free Choice and Healthcare Travel Costs
Insurance Co.s loading premiums and declining insurance work
IRMER 2000 (X-Rays)
Jury Service
LINKs - Local Involvement Networks
MRSA and C difficile and Healthcare acquired Infections
MRSA swabs for hospitals
NHS Number
Nursing Homes & Residential Homes
Overseas Patients
Pandemic Flu
Pathology Results-patient contact details
Patient Participation Groups - PPGs
Patient Transport
Practice Letterheads
Recycling paper containing sensitive data
Reducing Paperwork
Registering Patients
Removing Patients From Your List
Root Cause Analysis (RCA) MRSA
Telephone systems
Temporary Patients
Waiting Room music
Work Capability Tests
Veterans
Premises Issues
Prescribing & Dispensing
Private Work
Referrals
Safeguarding
Sessional Doctors, Locums and non-Principals page
Vaccination
Core National Documents and legislation
Focus On
What's new pages
 
www.intergage.co.uk